Your browser doesn't support javascript.
loading
All-oral longer regimens are effective for the management of multidrug-resistant tuberculosis in high-burden settings.
Khan, Palwasha Y; Franke, Molly F; Hewison, Catherine; Seung, Kwonjune J; Huerga, Helena; Atwood, Sidney; Ahmed, Saman; Khan, Munira; Sultana, Tanha; Manzur-Ul-Alam, Mohammad; Vo, Luan N Q; Lecca, Leonid; Yae, Kalkidan; Kozhabekov, Serik; Tamirat, Meseret; Gelin, Alain; Vilbrun, Stalz C; Kikvidze, Marina; Faqirzai, Jamil; Kadyrov, Abdullaat; Skrahina, Alena; Mesic, Anita; Avagyan, Nana; Bastard, Mathieu; Rich, Michael L; Khan, Uzma; Mitnick, Carole D.
  • Khan PY; Interactive Research and Development Global, Singapore palwasha.khan@lshtm.ac.uk.
  • Franke MF; Clinical Research Dept, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
  • Hewison C; These authors contributed equally.
  • Seung KJ; Partners In Health, Boston, MA, USA.
  • Huerga H; Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
  • Atwood S; These authors contributed equally.
  • Ahmed S; Medical Dept, Médecins Sans Frontières, Paris, France.
  • Khan M; Partners In Health, Boston, MA, USA.
  • Sultana T; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA.
  • Manzur-Ul-Alam M; Field Epidemiology Dept, Epicentre, Paris, France.
  • Vo LNQ; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA.
  • Lecca L; Interactive Research and Development, Karachi, Pakistan.
  • Yae K; Interactive Research and Development, Durban, South Africa.
  • Kozhabekov S; Interactive Research and Development, Dhaka, Bangladesh.
  • Tamirat M; Interactive Research and Development, Dhaka, Bangladesh.
  • Gelin A; Interactive Research and Development Global, Singapore.
  • Vilbrun SC; Friends for International TB Relief, Ho Chi Minh City, Vietnam.
  • Kikvidze M; Socios En Salud Sucursal Peru, Lima, Peru.
  • Faqirzai J; Partners In Health, Ethiopia, Addis Ababa, Ethiopia.
  • Kadyrov A; Partners In Health, Almaty, Kazakhstan.
  • Skrahina A; Partners In Health, Lesotho, Maseru, Lesotho.
  • Mesic A; Zanmi Lasante, Port-au-Prince, Haiti.
  • Avagyan N; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
  • Bastard M; Médecins Sans Frontières, Georgia.
  • Rich ML; Médecins Sans Frontières, Armenia.
  • Khan U; Médecins Sans Frontières, Kyrgyzstan.
  • Mitnick CD; Médecins Sans Frontières, Belarus.
Eur Respir J ; 59(1)2022 01.
Article en En | MEDLINE | ID: mdl-34140298
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Antituberculosos Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Antituberculosos Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article